Know Cancer

or
forgot password

Effects of Physical Activity on the Endothelial and Cardiac Function of Patients With Renal Cell Carcinoma Receiving a Thyrosine Kinase Inhibitor (Sunitinib)


Phase 3
18 Years
75 Years
Open (Enrolling)
Both
Renal Cell Carcinoma

Thank you

Trial Information

Effects of Physical Activity on the Endothelial and Cardiac Function of Patients With Renal Cell Carcinoma Receiving a Thyrosine Kinase Inhibitor (Sunitinib)


Inclusion Criteria:



- 18 to 75 years

- Understanding of written German

- Treatment with Sunitinib

- Ability to walk

Exclusion Criteria:

- Cardiovascular, pulmonary or osteoarticular disease which can be aggravated by
exercise

- BMI < 18 or > 30

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care

Outcome Measure:

Fatigue

Outcome Time Frame:

12 weeks

Safety Issue:

No

Authority:

Germany: Ethics Commission

Study ID:

SUIR8687

NCT ID:

NCT00869011

Start Date:

December 2009

Completion Date:

Related Keywords:

  • Renal Cell Carcinoma
  • Cancer
  • renal cell carcinoma
  • fatigue
  • exercise
  • Carcinoma
  • Carcinoma, Renal Cell

Name

Location